| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6185880 | Gynecologic Oncology | 2009 | 9 Pages |
Abstract
The quantitation of circulating tumor-reactive IgG can be used to identify the presence of ovarian cancer. The analyses of IgG recognition of specific exosomal antigens allows for the differentiation of women with benign ovarian masses from ovarian cancer, as well as distinguishing early and late stage ovarian cancers. Thus, the quantitative assessment of IgG reactive with specific tumor-derived exosomal proteins can be used as diagnostic markers for ovarian cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Douglas D. Taylor, Cicek Gercel-Taylor, Lynn P. Parker,